Unresponsiveness of intrahepatic lymphocytes to bacterial superantigen: rapid development of suppressive Mac-1(high) cells in the mouse liver.
We previously found that a small dose (2 microg per mouse) of staphylococcal enterotoxin B (SEB) induced early emerging unresponsiveness in intrahepatic-lymphocyte populations (IHLs). The purpose of this study was to reveal the inducing role of accessory cells involved in IHLs in this phenomenon. IHLs prepared at 3 to 24 hours after SEB injection failed to proliferate in response not only to SEB but also to SEA, representing ligand-nonspecific unresponsiveness, whereas spleen cells (SPCs) and mesenteric lymph-node cells showed transient proliferation. Unresponsiveness in IHLs was related to a deficit of their accessory cell function as measured by coculture of irradiated IHLs and antigen-specific, type 1 T-helper (Th1) clone cells. High levels of nitrite were detected in the culture supernatant. Supplement of N(G)-monomethyl-L-arginine lowered nitrite levels and concurrently restored the proliferative response of Th1 cells, indicating the involvement of nitric oxide in suppression. Adherent cells prepared from IHLs well reproduced these results. As shown by flow cytometry, Mac-1(high) Ia(+) cells, which mainly included F4/80(+) cells (macrophages) and a minor population of CD11c(+) cells (dendritic cells), increased in proportion in IHLs but not in SPCs at 6 to 24 hours. Depletion of Mac-1(high) cells from IHLs with antibody-coated magnetic beads recovered the proliferative response. Depleted Mac-1(high) cells had a monocytoid appearance. In immunostained sections, Kupffer cells came to highly express both Mac-1 and Ia at 12 hours. These results indicate that Mac-1(high)Ia(+) adherent cells, largely Kupffer cells activated by SEB, nonspecifically suppress the proliferation of Th1 cells via nitric oxide production before manifestation of ligand-specific unresponsiveness.
Terabe
M
M
Department of Microbiology and Immunology, Nippon Medical School, Tokyo, Japan.
Shimizu
M
M
Mabuchi
A
A
Matui
S
S
Morikawa
H
H
Kaneda
K
K
Kakiuchi
T
T
Yokomuro
K
K
D000818:Animals; D000938:Antigen-Presenting Cells / Q000502:physiology; D002452:Cell Count / Q000187:drug effects; D004768:Enterotoxins / Q000494:pharmacology*; D005260:Female; D000949:Histocompatibility Antigens Class II / Q000378:metabolism; D007728:Kupffer Cells / Q000378:metabolism*; D008024:Ligands; D008099:Liver / Q000166:cytology* / Q000378:metabolism*; D008198:Lymph Nodes / Q000166:cytology / Q000187:drug effects; D008214:Lymphocytes / Q000187:drug effects*; D008643:Mesentery; D051379:Mice; D008807:Mice, Inbred BALB C; D009573:Nitrites / Q000378:metabolism; D013154:Spleen / Q000166:cytology / Q000187:drug effects / Q000502:physiology; D018089:Superantigens / Q000494:pharmacology*; D050378:T-Lymphocytes, Regulatory / Q000378:metabolism*
D004768:Enterotoxins; D000949:Histocompatibility Antigens Class II; D008024:Ligands; D009573:Nitrites; D018089:Superantigens; C031818:enterotoxin B, staphylococcal